Brigham and Women's Hospital
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Brigham and Women's Hospital sits in the top decile of US sponsors by registered trial count (#35 of 15,742 sponsors by registered trial count).
Brigham and Women's Hospital: 937 sponsored US clinical trials, 145 recruiting.
Brigham and Women's Hospital sponsors 937 registered US clinical trials on ClinicalTrials.gov, 145 of them currently recruiting, and 608 completed. 124 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 13 trials.
Top-decile sponsor footprint
Brigham and Women's Hospital ranks in the top decile of sponsors by registered trial count (#35 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
608 of 677 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
937 total, page 13 of 19
Impact of Music on Satisfaction, Anxiety, and Hemodynamics During Spinal Anesthesia for Cesarean Delivery
NCT02732964
Belatacept Conversion in Proteinuric Kidney Transplant Recipients
NCT02327403
Comparing Methods to Biopsy Pancreas Mass
NCT01663493
Group-based Peer Support Versus Individual Education for Patients Undergoing CPAP Treatment
NCT02538419
Music During Labor Epidural Placement and Patient Satisfaction
NCT02734056
Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia
NCT02147626
Imputation of PaO2 From SaO2
NCT02598492
Intrathecal Hydromorphone for Labor Analgesia
NCT02277782
Pharmacoeconomics and Related Patient Outcomes of Multi-dose Intravenous Acetaminophen (OFIRMEV)
NCT02369211
The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study
NCT02253394
Strategies to Reduce Injuries and Develop Confidence in Elders
NCT02475850
Motivational Interviewing to Enhance Adherence of Patients With Psychogenic Non-epileptic Seizures
NCT02598076
Tele-Pharmacy Intervention to Improve Treatment Adherence
NCT02512276
Improving Surgical Safety of Seniors Through Preoperative Cognitive Screening
NCT02570438
Characterizing Upper Airway Collapse to Guide Patient Selection for Oral Appliance Therapy for Obstructive Sleep Apnea
NCT02489591
COcoa Supplement and Multivitamin Outcomes Study
NCT02422745
Comparison of Ultrasound Guided Peripheral IV Placement With and Without Use of a Guidewire
NCT02422472
Genomic Sequencing for Childhood Risk and Newborn Illness
NCT02422511
Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered
NCT02969343
Effect of Desipramine on Upper Airway Collapsibility and Genioglossus Muscle Activity in Patients With Obstructive Sleep Apnea - Study B
NCT02436031
Stress and the Nervous System
NCT02339506
Safety Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)
NCT02425579
Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects
NCT02422446
Associated Joint Pain With Controlled Ankle Movement (CAM) Walker Boot Wear
NCT03312933
Development of Countermeasures Against Adverse Metabolic Effects of Shift Work
NCT02291952
Effect of Desipramine on Genioglossus Muscle Activity in Healthy Adults Study A
NCT02428478
Tiagabine to Enhance Slow Wave Sleep in Patients With Sleep Apnea
NCT02387710
Improving Sleep for Healthy Hearts
NCT02848859
Assessment of Ventilation Using Respiratory Volume Monitor Compared to Capnography During Intravenous Sedation
NCT02860143
Using Emergency Manuals During Interprofessional Crisis Management: Are There Unintended Consequences?
NCT03006549
Effects of Clobazam on Sleep and Daytime Function in Patients With Epilepsy
NCT02911025
Tau Imaging of Chronic Traumatic Encephalopathy
NCT02191267
Improving Teamwork in an Academic, Tertiary Care Labor and Delivery Unit
NCT02368535
Myocardial Perfusion Echocardiography to Detect Human Heart Transplant Rejection
NCT02300870
Neuroimaging Effects of Cognitive Behavioral Therapy in Fibromyalgia
NCT01345344
Intrathecal Hydromorphone for Post-cesarean Delivery Pain - a Dose Finding Study
NCT01943565
Effect of Dietary Habits on Metabolic Health
NCT02298790
Targeting Cognition in Bipolar Disorder With Pramipexole
NCT02397837
Prediction of Persistent Post-Mastectomy Pain
NCT02329574
Trial of Feedback on Blood Use
NCT02232568
Focused Palliative Care Intervention in Advanced Heart Failure
NCT02805712
Mail Outreach To Increase Vaccination Acceptance Through Engagement
NCT02243774
Atrial Fibrillation, Cardiac Symptoms, and Anxiety
NCT02133365
Preoperative Cognitive Screening of Surgical Patients 65 Years of Age or Older
NCT02570451
Deferoxamine to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
NCT02216513
Does Maternal Fever During Labor Analgesia Has Any Relationship With Maternal Ventilation?
NCT02339389
Intervention With Vitamin D and Omega-3 Supplements and Incident Heart Failure
NCT02271230
Recent GDM Lifestyle Intervention
NCT01910805
Trial of Dialysate Sodium in Chronic Hospitalized Hemodialysis Patients
NCT02145260
Safety and Efficacy of Saxagliptin for Glycemic Control in Non-Critically Ill Hospitalized Patient
NCT02182895
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 90 |
| Phase 2 | 107 |
| Phase 3 | 47 |
| Phase 4 | 77 |
Therapeutic Areas
What is open in the Brigham and Women's Hospital pipeline
145 recruiting of 937 indexed (15% open); 608 completed (65%).
Phase mix: 124 late (III/IV) vs 197 early (I/II) (early-phase heavy).
Top condition: Type 2 Diabetes (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Brigham and Women's Hospital: open-pipeline peers nationwide
Peers matched on 937 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Brigham and Women's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 937 trials (± recruiting share)
- Columbia University · 958 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of Minnesota · 966 trials · 19% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Incyte Corporation · 15% recruiting · 239 trials
- Northwestern University · 15% recruiting · 1,209 trials
- Nationwide Children's Hospital · 15% recruiting · 188 trials
- University of Michigan Rogel Cancer Center · 15% recruiting · 292 trials
Related
What to do with this Brigham and Women's Hospital page
937 registered trials is a research-attention snapshot, not an endorsement of Brigham and Women's Hospital or any single study.
- 145 of Brigham and Women's Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 2 Diabetes is the condition Brigham and Women's Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Brigham and Women's Hospital pipeline card: 937 registered trials from official public datasets.Report a data error.